A Review of Antifungals and their Mono- and Combination- therapy in the Treatment of Invasive Fungal Infections

Invasive fungal infections with high mortality rate are a growing health concern in hospitals and medical centers. The infection usually occurs in people with compromised immune systems. The purpose of this paper is a review of the most commonly prescribed antifungal drugs for invasive fungal diseas...

Full description

Bibliographic Details
Main Authors: Amir Arastefar, Parisa Badiee
Format: Article
Language:English
Published: Kerman University of Medical Sciences 2016-11-01
Series:Journal of Kerman University of Medical Sciences
Subjects:
Online Access:https://jkmu.kmu.ac.ir/article_41284_e18eafa902daa800a96e69245500829c.pdf
_version_ 1797790704824483840
author Amir Arastefar
Parisa Badiee
author_facet Amir Arastefar
Parisa Badiee
author_sort Amir Arastefar
collection DOAJ
description Invasive fungal infections with high mortality rate are a growing health concern in hospitals and medical centers. The infection usually occurs in people with compromised immune systems. The purpose of this paper is a review of the most commonly prescribed antifungal drugs for invasive fungal diseases. Antifungals consist of the four main groups; polyenes, azoles, echinocandins and DNA and RNA synthesis inhibitors. Amphotericin B is one of the most significant antifungal agents effective against Aspergillus, Candida and Mucor species, but due to several side effects, it is not used for prophylaxis. Its lipid formulation has lower toxicity. Azoles have an extensive activity against a broad spectrum of filamentous fungi and Candida species. Voriconazole is the drug of choice in the prophylaxis and treatment of the patients susceptible to Aspergillus infections. Posaconazole is an oral azole used to treat mucormycosis.5-fluorocytosine is an antifungal drug with intracellular mechanisms that is used routinely for the treatment of cryptococcal meningitis. Echinocandins are the latest family of antifungal agents and include caspofungin, anidulafungin and micafungin. They are effective against Candida and can serve as an alternative for azoles. There is a variety of antifungal treatments and monotherapy has been the best; however, to prevent side effects of a medicine with high-dose and resistance, combination treatments are under investigation.
first_indexed 2024-03-13T02:08:21Z
format Article
id doaj.art-a400942e02ba40178ff981e89936db1c
institution Directory Open Access Journal
issn 2008-2843
language English
last_indexed 2024-03-13T02:08:21Z
publishDate 2016-11-01
publisher Kerman University of Medical Sciences
record_format Article
series Journal of Kerman University of Medical Sciences
spelling doaj.art-a400942e02ba40178ff981e89936db1c2023-07-01T05:23:35ZengKerman University of Medical SciencesJournal of Kerman University of Medical Sciences2008-28432016-11-0123682984241284A Review of Antifungals and their Mono- and Combination- therapy in the Treatment of Invasive Fungal InfectionsAmir Arastefar0Parisa Badiee1Master of Biotechnology, Alborzi Research Center, Shiraz Namazi Hospital, Shiraz, IranAssociate Professor of Mycology, Shiraz University of Medical Sciences, Shiraz, IranInvasive fungal infections with high mortality rate are a growing health concern in hospitals and medical centers. The infection usually occurs in people with compromised immune systems. The purpose of this paper is a review of the most commonly prescribed antifungal drugs for invasive fungal diseases. Antifungals consist of the four main groups; polyenes, azoles, echinocandins and DNA and RNA synthesis inhibitors. Amphotericin B is one of the most significant antifungal agents effective against Aspergillus, Candida and Mucor species, but due to several side effects, it is not used for prophylaxis. Its lipid formulation has lower toxicity. Azoles have an extensive activity against a broad spectrum of filamentous fungi and Candida species. Voriconazole is the drug of choice in the prophylaxis and treatment of the patients susceptible to Aspergillus infections. Posaconazole is an oral azole used to treat mucormycosis.5-fluorocytosine is an antifungal drug with intracellular mechanisms that is used routinely for the treatment of cryptococcal meningitis. Echinocandins are the latest family of antifungal agents and include caspofungin, anidulafungin and micafungin. They are effective against Candida and can serve as an alternative for azoles. There is a variety of antifungal treatments and monotherapy has been the best; however, to prevent side effects of a medicine with high-dose and resistance, combination treatments are under investigation.https://jkmu.kmu.ac.ir/article_41284_e18eafa902daa800a96e69245500829c.pdfpolyenesazolesechinocandinsamphotericin bfluconazole
spellingShingle Amir Arastefar
Parisa Badiee
A Review of Antifungals and their Mono- and Combination- therapy in the Treatment of Invasive Fungal Infections
Journal of Kerman University of Medical Sciences
polyenes
azoles
echinocandins
amphotericin b
fluconazole
title A Review of Antifungals and their Mono- and Combination- therapy in the Treatment of Invasive Fungal Infections
title_full A Review of Antifungals and their Mono- and Combination- therapy in the Treatment of Invasive Fungal Infections
title_fullStr A Review of Antifungals and their Mono- and Combination- therapy in the Treatment of Invasive Fungal Infections
title_full_unstemmed A Review of Antifungals and their Mono- and Combination- therapy in the Treatment of Invasive Fungal Infections
title_short A Review of Antifungals and their Mono- and Combination- therapy in the Treatment of Invasive Fungal Infections
title_sort review of antifungals and their mono and combination therapy in the treatment of invasive fungal infections
topic polyenes
azoles
echinocandins
amphotericin b
fluconazole
url https://jkmu.kmu.ac.ir/article_41284_e18eafa902daa800a96e69245500829c.pdf
work_keys_str_mv AT amirarastefar areviewofantifungalsandtheirmonoandcombinationtherapyinthetreatmentofinvasivefungalinfections
AT parisabadiee areviewofantifungalsandtheirmonoandcombinationtherapyinthetreatmentofinvasivefungalinfections
AT amirarastefar reviewofantifungalsandtheirmonoandcombinationtherapyinthetreatmentofinvasivefungalinfections
AT parisabadiee reviewofantifungalsandtheirmonoandcombinationtherapyinthetreatmentofinvasivefungalinfections